Forty-four of the 50 states of the United States of America are suing a collection of drug companies for allegedly inflating the prices of prescription drugs.
The sweeping lawsuit alleges that drug companies conspired to inflate the prices of more than 100 different drugs.
Among the drugs are those that treat HIV, asthma, depression, learning disabilities and more.
Pfizer, Mylan, Novartis, and Teva have all been named in the lawsuit.
In total, more than a dozen generic drug companies and numerous executives were identified in the suit.
The lawsuit claims that executives at various pharmaceutical companies secretly conspired to fix prices, which is illegal.
In order to cover their tracks, most of the executives avoided written records.
News for the Informed American Patriot
Sign up for our twice-daily emails and stay up-to-date on the most important news and commentary!
Instead, they used golf outings, luncheons, conferences and the like to coordinate efforts.
Reportedly, the drug companies sought to maintain what they thought were “fair shares” of the generic drugs market.
The lawsuit purports that the bulk of the collusion occurred between July of 2013 and January of 2015.
During this time frame one drug company, Teva, raised prices on roughly 400 formulates of 112 different drugs.
This could become one of the biggest legal battles in history — with implications that could reshape the entire pharmaceutical industry.
Teva has been identified as the leader in the conspiracy.
However, prosecutors claim that the conspiracy was industry-wide. With 44 states signed onto the case, it could become one of the biggest legal battles in history — with implications that could reshape the entire pharmaceutical industry.
Teva and other drug companies are denying the allegations.
Brian Brinker is a political consultant and has an M.A. in global affairs from American University. This OpsLens piece is used by permission.
The opinions expressed by contributors and/or content partners are their own and do not necessarily reflect the views of LifeZette.